A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report

The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-line treatment option for people who cannot tolerate platinum. Immunotherapy is pre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Wang, Jianzheng, Li, Qingli, Lv, Huifang, Nie, Caiyun, Chen, Beibei, Xu, Weifeng, Yang, Tiejun, Zhang, Yinping, Tu, Shuiping, Chen, Xiaobing
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8249845/
https://ncbi.nlm.nih.gov/pubmed/34221988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.671416
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires